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otic cytolysin, Equinatoxin II (EqtII). EqtII activity is known to depend on the presence of sphingomyelin in the target membrane
and is enhanced by lipid phase separation. By imaging the ionic flux through individual pores in vitro, we observe that EqtII pores
form predominantly within the liquid-disordered phase. We observe preferential binding of labeled EqtII at liquid-ordered/liquid-
disordered domain boundaries before it accumulates in the liquid-disordered phase.INTRODUCTIONPore-forming proteins such as Equinatoxin II (EqtII) play a
key role in all kingdoms of life. In bacteria they are impor-
tant virulence factors (1,2), whereas in mammals they typi-
cally play the opposite role and are involved in host immune
response (3,4). In general, pore-forming proteins undergo
large conformational changes after binding to the target
membrane, transitioning from a water-soluble monomer to
an inserted multimeric pore with the potential to kill the
target cell (2,5). This pore-formation mechanism is often
facilitated by a specific, high-affinity receptor such as a
transmembrane protein, lipid anchored protein, lipid, or
lipid cluster.
EqtII is a member of actinoporin protein family (6–8). In
contrast to the more widely studied b-barrel pore-forming
toxins, actinoporins insert a-helices to permeabilize target
cell membranes. Isolated from the sea anemone Actinia
equina, EqtII is believed to play a role in paralyzing prey
and defending against predators (6,9). EqtII is a ~20 kDa pro-
tein with high affinity for sphingomyelin (SM)-containing
lipid membranes (10,11). EqtII and other actinoporins
bind to the lipid membrane through a cluster of exposed
aromatic residues and a nearby phosphocholine-binding
site (10,12,13). The key step in EqtII pore formation is the
conformational change that transfers the N-terminal a-helix
across themembrane (12,14). The currentmodel for the EqtII
pore is one inwhich a single pore is formed from three or four
monomers (15). Given this small number of contributing
monomers but broad distribution of pore conductance (7),
it is likely that the pore walls constitute not only a-helices
but also a torus of lipids (16). However, recent crystallo-
graphic data on the EqtII homolog fragaceatoxin C disagree
with this model and suggest a nonameric pore for actinopor-
ins, which would not include membrane lipids (17).
EqtII was previously reported to bind preferentially to
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layers (18) and giant unilamellar vesicles (GUVs) (19).
In vivo studies also showed that EqtII association with the
plasma membrane leads to reorganization of the membrane
and formation of microscopic domains, where the toxin
preferentially colocalizes with raft proteins (20). In addi-
tion, although pore formation by EqtII requires SM (21),
SM itself is not sufficient for the N-terminal a-helix confor-
mational change that leads to pore formation (22); another
factor is also required. These results led to the suggestion
that the presence of lipid domains might play an important
role in the pore-formation mechanism, and that EqtII
acts not only to form pores but also to remodel the mem-
brane (19).
Here, we investigated the role of Lo/Ld phase separation
on EqtII pore formation using droplet interface bilayers
(DIBs) (23,24). DIBs are made by contacting nanoliter
aqueous droplets in an oil solution in the presence of phos-
pholipids. Lipid monolayers form at each oil/water interface
and when two such monolayers touch, a bilayer is created.
DIBs can be used to simplify single-molecule fluorescence
imaging of a lipid bilayer while retaining gigaohm seals
of the membrane (25,26). Using total internal reflection
fluorescence (TIRF) microscopy of phase-separated DIBs,
we observed that EqtII distributed predominantly into the
Ld phase, and that pores also formed within this phase.
We confirmed previous work showing that EqtII localizes
at the Lo/Ld phase boundary, and then examined the time
dependence of this phenomenon. We observed preferential
accumulation of EqtII in the Ld phase over the Lo phase.
These observations support previous measurements on lipid
monolayers (18) and conflict with those obtained in GUVs
(19). One must always take care when extrapolating results
from in vitro experiments to the in vivo action of EqtII. For
example, Sezgin and co-workers (27) recently showed that
the partitioning of raft proteins is dependent on the prepara-
tion method in phase-separated giant plasma membrane ves-
icles. It is therefore possible that beyond simple demixing,
the relative degree of ordering between phases present inhttp://dx.doi.org/10.1016/j.bpj.2013.11.4507
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membrane and hence affect the mechanistic outcome.
Such differences might help explain the differences between
these observations and those made previously in GUVs.MATERIALS AND METHODS
Materials
All materials were obtained from Sigma-Aldrich unless otherwise speci-
fied, and used without further purification. All buffers were filtered before
use (0.2 mm cellulose acetate; Nalgene) and buffers used to make DIBs
were treated with Chelex 100 ion exchange resin (biotechnology grade,
100–200 mesh; BioRad). 1,2-Diphytanoyl-sn-glycero-3-phosphocholine
(DPhPC), egg SM (eSM; egg, chicken), and cholesterol (Chol; ovine
wool) were obtained from Avanti Polar Lipids, and 1,10-dioctadecyl-
3,3,30,30-tetramethylindocarbocyanine perchlorate (DiIC18 (3); DiI),
3,30-dilinoleyloxacarbocyanine perchlorate (FAST DiO; DiOC18 (2)), and
N-(6-tetramethylrhodaminethiocarbamoyl) 1,2-dihexadecanoyl-sn-glyc-
ero-3-phosphoethanolamine (TRITC-DHPE) were obtained from Invitro-
gen. The calcium indicator Fluo-8H (sodium salt; ABD Bioquest) was
used for all experiments imaging the ionic flux through EqtII pores.FIGURE 1 Schematic. A Droplet Interface Bilayer is formed between an
agarose-coated microscope coverslip and an aqueous droplet in a solution
of lipids in hexadecane. (A) Monolayers form at droplet/agarose interfacesPurification, labeling, and characterization
of EqtII
An A179C mutant of EqtII was expressed recombinantly in Escherichia
coli BL21 (DE3). This C-terminal mutation has been shown to be amenable
to modifications without affecting permeabilizing activity (28). The C-ter-
minus is distant from parts of the molecule that participate in membrane
binding (11,12,29) or formation of the final transmembrane pore (14,30)
and are likely to be fully exposed to the solvent in both the membrane-
bound and pore form of the protein (28,31). EqtII A179C was purified as
described previously (32) in the presence of 2 mM dithiothreitol (DTT)
to prevent oxidation of the thiol group. After chromatography, the protein
was concentrated by ultrafiltration and washed thoroughly with degassed
buffer (20 mM phosphate, pH 7.2) to remove the DTT before labeling
with Cy3B maleimide (GE Healthcare). Cy3B maleimide (5 mg mL1 in
dimethyl sulfoxide) was mixed with the A179C solution to a final molar
dye/protein ratio of 4:1. The reaction mixture was incubated in the dark
at ambient temperature for 2 h. Labeled A179C (EqtII-Cy3B) was separated
from the unreacted dye by fast protein liquid chromatography (HiPrep ion
exchange; GE Healthcare). Finally, EqtII-Cy3B was concentrated using a
Centricon ultrafiltration membrane (3 kDa MWCO; Millipore) to a final
concentration of 75 mM. Efficiency of labeling was measured from the
absorbance spectrum with a dye/protein ratio of 1.01 5 0.02. Labeling
was also confirmed by SDS-PAGE gel scanned under UV light before
Coomassie staining (Fig. S1 A in the Supporting Material).
EqtII-Cy3B activity was assessed via hemolysis of bovine red blood cells
as described previously (29). The bovine red blood cells were washed three
times with erythrocyte buffer (130 mM NaCl, 20 mM Tris-HCl, pH 7.4).
Serial twofold dilutions of the protein were made in microtiter plate into
a final volume of 100 mL of erythrocyte buffer. The same volume of eryth-
rocyte suspension in erythrocyte buffer (A630¼ 0.5) was added to each well
and hemolysis was monitored as a decrease in absorption at 630 nm for
20 min at room temperature. The hemolytic activity of the EqtII A179C
mutant and Cy3B-labeled mutant (EqtII-Cy3B) was indistinguishable
from that of the wild-type protein (Fig. S1 B).
in a microfabricated device. (B) Piezo-driven nanoinjection from a glass
pipette is used to deliver EqtII-Cy3B to the droplet. (C) Insertion of an
agarose-coated microelectrode into the droplet permits control of the
applied potential, and measurement of gigaohm seal single-channel cur-
rents. TIRF microscopy of the bilayer is possible through the coverslip.
To see this figure in color, go online.DIBs
DIBs were prepared as described previously (24,25) (Fig. 1). Briefly,
140 mL of molten 0.75% (w:v) low-melting-point agarose was depositedBiophysical Journal 106(8) 1630–1637
1632 Rojko et al.on a plasma-cleaned coverslip by spin coating (30 s at 4000 rpm). A micro-
channel device was fabricated from polymethyl methacrylate (PMMA)
(24). The purpose of this device was twofold: 1), to provide multiple wells
to contain the oil-lipid solution on top of the agarose-coated coverslip; and
2), to maintain the hydration of the substrate-agarose through contact of the
substrate with a network of agarose-filled channels. The microchannel de-
vice was placed on top of the coverslip and filled with rehydrating agarose
(1.5 M KCl, 10 mM HEPES, pH 7). Lipid solutions were prepared by dry-
ing a film of lipid from chloroform before adding hexadecane. Lipids dis-
solved in hexadecane were pipetted into the device wells. Solutions of
Chol in hexadecane were either pipetted into the wells before bilayer forma-
tion or added to the wells after the bilayer was already formed, as indicated
in the respective results. Then 50 nL droplets (1.5 M KCl, 10 mM HEPES,
pH 7) were prepared in the hexadecane lipid mixture and pipetted into the
microchannel device after 15 min. A lipid bilayer spontaneously formed at
the interface between the agarose substrate and the aqueous droplet. For
calcium flux imaging, 750 mM CaCl2 was added to the rehydrating agarose
solution, and droplets contained 50 mM Fluo-8H and 370 mM EDTA in
addition to 1.5 M KCl, 10 mM HEPES, at pH 7.Droplet nanoinjection
Borosilicate capillaries were pulled to an ~10 mm inner diameter and back-
filled with hexadecane before they were attached to a piezo-driven injector
(Nanoliter 2000; World Precision Instruments). Protein solution was loaded
into the capillary (typically 200 nL) by piston displacement causing suction.
The injector was manipulated into position through the use of a three-
dimensional micromanipulator (Narishige, Japan). A set volume of protein
solution (usually 4.6 nL) was then introduced into a droplet by bringing the
capillary tip into contact with the droplet and ejecting the solution into the
droplet as described previously (26).Fluorescence imaging
We measured fluorescence using an inverted microscope (Ti-E; Nikon). We
used 532 nm (Compass 215M; Coherent) and 473 nm (Shanghai Dream
Lasers Technology) laser excitation to image Cy3B and DiOC18 (2) fluores-
cence, respectively. The excitation light was focused at the back aperture of
an oil immersion objective lens (60  Plan Apo N.A. 1.4; Nikon) so that it
was totally internally reflected at the coverslip surface. Emitted fluores-
cence was collected through the same objective, transmitted through
suitable dichroic and emission filters (HQ595/50M and HHQ550LP
(Chroma) for Cy3B emission, and 525/30 (Semrock) for Fluo8H and
DiOC18 (2) emission). Images were recorded with the use of electron-multi-
plying CCDs (iXonþDV860E or iXon3 DU860; Andor Technology). Tem-
perature was controlled with a heated microscope stage (PE100; Linkam
Scientific Instruments).Pore diffusion
We determined the location of individual EqtII pores by tracking the posi-
tion of fluorescent spots corresponding to Ca2þ ion flux through each pore.
For spots that moved during an image sequence, we used the Trackmate
(33) algorithm compiled for ImageJ (34) (http://fiji.sc/TrackMate) to track
all pores present on the bilayer. Individual mean-squared displacements
versus time lag were computed for each pore, and the gradient of each
plot (4Dlatt) was used to generate a distribution of diffusion coefficients
(Fig. 2 D).Electrical measurements
An Ag/AgCl electrode in the droplet and an equivalent ground electrode in
the agarose enabled electrical measurements and control of transmembraneBiophysical Journal 106(8) 1630–1637potential. Currents were recorded with a patch-clamp amplifier (Axopatch
200B; Axon Instruments) and Windows Electrophysiology Disk Recorder
software (WinEDR, John Dempster Strathclyde Institute of Pharmacy and
Biomedical Science). A postacquisition 1 kHz low-pass filter was applied.
The microchannel device, electrodes, and patch-clamp head stage were
all enclosed in a purpose-built Faraday cage attached to the inverted
microscope.RESULTS
We measured ionic flux through Cy3B-EqtII pores from the
localized fluorescence caused by Fluo8H binding to calcium
ions as they passed from the substrate agarose through the
pore into the droplet. We also measured the time-dependent
changes in the distribution of EqtII-Cy3B within DIBs
exhibiting liquid-disordered (Ld) and liquid-ordered (Lo)
phase coexistence.EqtII forms pores in the Ld phase
We observed pore formation and diffusion using the Ca2þ
indicator dye Fluo-8H in the droplet to obtain an optical
measurement of ionic flux (35). Under an applied potential
difference across the bilayer (60 mV), calcium ions pre-
sent in the agarose layer (750 mM) pass through the pore
and into the droplet. Chelation of this calcium by Fluo-8H
(50 mM) gives rise to a localized fluorescent spot at the loca-
tion of the pore. The bilayer was illuminated with 473 nm
laser light, and the Fluo-8H emission fluorescence due to
the calcium flux was imaged at the camera.
DIBs were formed with a lipid composition that exhibited
Lo/Ld phase coexistence (4:3:3 DPhPC/eSM/Chol). Using a
piezo-driven glass micropipette, we injected 4.6 nL of
10 mM Cy3B-labeled EqtII into the droplet. Cy3B emission
was used to determine EqtII location. Pore formation was
subsequently observed as the appearance of diffusing spots
corresponding to calcium flux across the bilayer (Fig. 2, A
and B).
Simultaneous single-channel electrical recording and
fluorescence imaging on bilayers at lower EqtII concentra-
tion (100 nM) using a bilayer without the complication of
phase coexistence (DPhPC:SM 9:1) enabled us to confirm
that Fluo-8H spot appearance correlated directly with ionic
current through a single EqtII pore (Fig. 2 C).
The bilayer area corresponding to EqtII binding coin-
cided with regions labeled with the Ld marker DiOC18 (2)
(Fig. 3 A). Other fluorescent markers of the Ld phase
(19,36,37) (DiI and TRITC-DHPE) supported this assign-
ment (Figs. S2 and S4). Lipid mixtures corresponding to
the expected two-phase and single-phase regions of the
phase diagram also supported this assignment (Fig. S3).
We quantified the preferential location of EqtII pores pre-
sent in Fig. 2 A by first tracking the location of the pores and
then comparing the pore locations with a binary image of
EqtII-Cy3B fluorescence. We generated the binary image
by applying a threshold to the EqtII-Cy3B image at the
FIGURE 2 EqtII-Cy3B pores diffuse and form
in the Ld phase. (A) EqtII-Cy3B pores were visual-
ized by the Ca2þ flux using Fluo-8H fluorescence
in a DPhPC/eSM/Chol 4:3:3 DIB. The edge of
the DIB is visible as an arc in the upper-right quad-
rant of the images. Pores form in the Ld phase.
Scale bar: 10 mm. Also see Movie S1. (B) Image
sequence from a 10  10 mm region of A,
100 ms per image, running left to right, showing
pore appearance in the Ld phase. (C) Simultaneous
measurement of Fluo8H Ca2þ flux (top trace) and
electrical current (bottom trace) from a single
EqtII-Cy3B pore. Inset images show the pore at
specific time points; scale bar: 5 mm. Applied po-
tential 60 mV. (D) Pore diffusion from the data
set in A was Brownian and fit to a g distribution
of diffusion coefficients (n¼ 3287). (E) The distri-
bution of pore intensities from the data in A shows
distinct peaks. Data were fit to the sum of three log-
normal distributions. (F) The rate of pore appear-
ance over the timescale of our experiment was
constant. To see this figure in color, go online.
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togram of pixel intensities (i.e., between the histogram
peaks corresponding to dark and light areas). We assigned
95% (n ¼ 3287) of pore locations to the Ld phase. For those
pores assigned to the Lo phase, manual inspection of the
original image showed failure of image thresholding to
assign small low-contrast features to the correct phase.
Pore formation initiated only from within the Ld phase,
and not from the phase boundary or the Lo phase (Fig. 2,
A and B; Movie S1).We also examined the diffusive behavior of pores. Within
a single experiment, pore diffusion was Brownian, and the
distribution of diffusion coefficients (Fig. 2 D) could be fit
with a single g distribution (q ¼ 0.78 5 0.03, m ¼ 2.4 5
0.1 mm2 s1). In interpreting this result, we must caution
that between different experiments on different bilayers,
although diffusion was always Brownian and always
described by a single-component distribution, we observed
significant variation in the mean diffusion coefficient. We
believe these changes correspond to variation in theBiophysical Journal 106(8) 1630–1637
FIGURE 3 EqtII-Cy3B preferentially localizes to
the domain boundary before being found in the Ld
phase. (A) First row: A DPhPC/eSM/Chol 4:1:1
bilayer containing 0.1% DiOC18 (2) as a marker
for Ld phase was formed. Second row: EqtII-Cy3B
(1 mM) was injected into the droplet to a final con-
centration of ~100 nM. (B) Image sequence showing
time-dependent accumulation of EqtII fluorescence
at the domain boundary. Scale bar: 10 mm. (C)
Line profile across the images in B. A relative offset
of 2000 a.u. between each trace has been applied for
clarity. (D) Time dependence of fluorescence from
the images in B taken from three regions of interest
(ROIs): inside the central domain (green solid line),
at the domain boundary (blue dotted line), and
outside the central domain (red dashed line). ROIs
are shown in Fig. S5. Error bars represent the SD
in pixel intensity for the ROIs. To see this figure in
color, go online.
1634 Rojko et al.hydration of the underlying agarose support, as dehydration
of the agarose over a period of 24 h resulted in all pores
becoming immobile.
The distribution of pore intensities revealed several
distinct peaks corresponding to different pore conductances
(Fig. 2 E). We observed similar peaks in optical ionic flux
for pore formation in the antimicrobial peptide Alamethicin
(38). Because these intensity changes are apparent in indi-
vidual diffusing pores (Fig. 2 C), the most likely explanation
is that different-sized EqtII pores are present, although we
cannot formally exclude the possibility that multiple pores
diffuse in a single diffraction-limited cluster. An assignmentBiophysical Journal 106(8) 1630–1637of multiple conductance states is consistent with the multi-
ple conductances reported for planar lipid bilayer recordings
of EqtII (15). Pore intensity scales linearly with pore current
for our applied potential (60 mV) (Fig. S6).
Once formed, pores persisted throughout the lifetime of
our observations (minutes). We did not observe pore
closure. Pores appeared at a uniform rate during our mea-
surements (Fig. 2 F). Although we did not attempt to quan-
tify the dependence of pore formation on EqtII, the surface
density of the pores did qualitatively increase with the con-
centration of EqtII-Cy3B added to the droplet. Averaged
over all our experiments, the mean bilayer area per pore
Imaging EqtII Pores 1635was 621 mm2 at 100 mM EqtII, whereas at 1 mM EqtII, the
mean bilayer area per pore decreased to 52 mm2.EqtII concentration is first enhanced at the phase
boundary and then in the Ld phase
To study more closely the effects of EqtII-Cy3B on bilayers
containing two phases, we formed bilayers using a DPhPC/
eSM/Chol lipid mixture at a 4:1:1 molar ratio. Subsequently,
EqtII-Cy3B (4.6 nL, 1 mM) was injected into the droplet to a
final concentration of ~100 nM, and its localization on the
bilayer was observed. At early times, EqtII-Cy3B appeared
concentrated at the domain boundaries (Fig. 3 A; Movie
S2). Note that, similarly to previous measurements on lipid
monolayers (18), the distribution of EqtII-Cy3 fluorescence
in the Lo phase appeared uneven. This phenomena was also
time dependent, and at early times there was an even and
equal distribution of fluorescence in both phases (Movie S2).
Over time, EqtII-Cy3B was found in the same areas as the
DiOC18 (2) dye, i.e., the Ld phase (Fig. 3 B). Although trans-
membrane peptides in general partition into Ld phases in
model membranes (39), this result was unexpected because
EqtII was previously observed to bind preferentially to the
Lo phase (19). The proportion of bilayer area in each phase
was also affected by the binding of EqtII to the lipid
bilayer: Ld domains shrank and Lo domains increased in
size (Fig. 3).
We examined the time dependence of fluorescence inten-
sity. At early times, EqtII-Cy3B was enriched at the phase
boundary between the domains (Fig. 3). This is in agree-
ment with previous non-time-dependent observations
(18,19). However, after this initial period of enhanced con-
centration at the phase boundary, we observed that EqtII
subsequently increased in concentration in the Ld phase,
where protein preferentially accumulates (Fig. 3).DISCUSSION
We observed that EqtII-Cy3B bound preferentially to the
interface between different lipid phases before being found
predominantly in the Ld phase (Fig. 3). With the time reso-
lution of our experiments, we did not detect any lag between
EqtII binding to Lo and Ld phases, and binding at the Lo/Ld
domain boundaries. Our results are consistent with a model
in which EqtII binding is SM dependent (10), causing a
preferential binding at domain boundaries where imperfect
lipid packing is present and SM headgroups may be more
exposed. Another potential cause of this preferential binding
would be simple saturation of favorable binding sites at the
domain boundaries, before accumulation of EqtII from solu-
tion to the Ld phase. However, given the apparently equal
distribution of EqtII in Ld and Lo phases at early times
(Fig. 3 B; Movie S2), followed by an increase of fluores-
cence in the Ld phase at longer times (Fig. 3 D), we do
not favor this interpretation.After initial binding at the interface, labeled EqtII was
found preferentially in the Ld domains (Fig. 3). This result
was somewhat unexpected because, although EqtII was pre-
viously observed to bind at the lipid interface, it was found
to locate preferentially to the Lo phase in GUVs composed
of a mixture of 1,2-dioleoyl-sn-glycero-3-phosphocholine,
stearyl-SM, and Chol (19). Given these conflicting results,
we cautiously confirmed localization of EqtII to the Ld
phase in our lipid system, both by using different fluorescent
probes that partition preferentially to the disordered phase
(Figs. 3, S2, and S4) and by observing compositions ex-
pected to correspond to single- or two-phase regions of
the phase diagram (Fig. S3). In agreement with our study,
Barlic et al. (18) observed a similar distribution of EqtII
in lipid monolayers composed of egg-PC, eSM, and Chol,
where EqtII preferentially localized to domain interfaces
and the Ld phase.
After localization of EqtII in the Ld phase, we observed
subsequent pore formation within the Ld phase by calcium
flux imaging and current measurements (Fig. 2, A–C). It
has been suggested that protein binding at domain bound-
aries aids pore formation by increasing the local concentra-
tion of toxin monomers (18,19). Here, however, we did not
observe pore formation at boundaries, but only within the Ld
phase (Movie S2). Pores in the Ld phase were not observed
to diffuse into the ordered phase. Pore formation was a rela-
tively rare event, with a significant concentration of non-
pore-forming EqtII present in the Ld phase. In agreement
with previous work on large unilamellar vesicles (15,40),
our data confirm the presence of a large protein pool in
the Ld domains, in which pore formation occurs. These ob-
servations are also in agreement with a study by Poklar et al.
(41), in which no EqtII insertion was observed in ordered
bilayers. GUVs that were composed of SM/Chol (1:1 ratio)
and in Lo phase were also not susceptible to pore formation,
even though EqtII did bind to them (19).
Given the results of these experiments, we suggest two
potential models of EqtII action: 1), preferential binding
at Lo/Ld domain boundaries followed by helix insertion,
diffusion of EqtII into the Ld phase, and then pore forma-
tion; and 2), binding at domain boundaries followed by satu-
ration of these binding sites, leading to dominant binding
occurring from solution to the Ld phase, and then subse-
quent insertion and pore formation from the Ld phase.
How might our observations be related to the in vivo ac-
tion of EqtII? To some extent, EqtII colocalizes in cells with
markers for lipid rafts (20), and homologous sticholysin II
localizes to detergent-resistant membranes (42). These re-
sults might be reconciled if EqtII preferentially binds to
the domain boundaries rather than to the Lo domains, or if
the Lo/Ld phase coexistence observed in this work is
different from that observed in vivo. Clearly, the situation
in cells is more complex, as was shown recently in a
comparative study that employed EqtII and another SM-
specific pore-forming toxin, lysenin, and found threeBiophysical Journal 106(8) 1630–1637
1636 Rojko et al.different pools of SM that were stained by either EqtII or
lysenin, or both (43).
Segregation at domain boundaries has been reported in a
number of systems, including simulations of lipid-packing-
driven a-helix segregation (39) and domain formation (44),
simulations of lipoproteins (45), and clustering at domain
boundaries in nonlipid amphiphiles (46). For example, a
combination of two-photon fluorescence microscopy and
atomic force microscopy imaging of N-Ras showed prefer-
ential binding to Ld domains and at Lo/Ld domain bound-
aries, similar to what we observed here for EqtII (47).
Domain boundaries clearly have a dramatic effect on the
mechanism of EqtII pore formation, and these effects have
been predicted more generally to play a key role in the pref-
erential adsorption and accumulation of membrane-span-
ning peptides (39). This domain-dependent mechanism
might also be generalized for other pore-forming toxins.
For example, the lipid-phase distribution of b-barrel pore-
forming toxins appears to depend on hydrophobic mismatch
between the bilayer thickness and the protein transmem-
brane segment, as was recently shown for the pore-forming
toxin perfringolysin O (48).SUPPORTING MATERIAL
Six figures and two movies are available at http://www.biophysj.org/
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